WallStSmart
MCTA

Charming Medical Limited Class A Ordinary Shares

NASDAQ: MCTA · HEALTHCARE · MEDICAL CARE FACILITIES

$29.36
+0.00% today

Updated 2026-09-11

Market cap
$445.55M
P/E ratio
419.36
P/S ratio
92.67x
EPS (TTM)
$0.07
Dividend yield
52W range
$4 – $32
Volume
0.9M

Charming Medical Limited Class A Ordinary Shares (MCTA) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2023202420252026
Total assets$6.38M$4.88M$5.36M$9.87M
Cash & equivalents$1.93M$2.10M$816771.00$4.70M
Current assets$4.12M$3.67M$3.37M$8.17M
Total liabilities$7.65M$6.03M$5.31M$4.69M
Current liabilities$7.17M$5.88M$4.95M$4.33M
Long-term debt
Shareholder equity$-1.16M$-1.08M$49243.00$5.18M
Retained earnings$-1.16M$-1.08M$119441.00$96793.00
Accounts receivable$2.12M$1.54M$579091.00$201477.00
Inventory$66332.00$28151.00$26797.00$25623.00
Goodwill

Frequently asked questions

What is Charming Medical Limited Class A Ordinary Shares's revenue?

Charming Medical Limited Class A Ordinary Shares's trailing twelve-month revenue is $4.81M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is MCTA?

In its most recent fiscal year, MCTA ran a gross margin of 62.58%, an operating margin of 2.68%, and a net margin of -0.47%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does MCTA generate?

MCTA produced $-1.56M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MCTA's balance sheet healthy?

MCTA holds $4.70M in cash and equivalents against — in long-term debt, on $5.18M of shareholder equity. That debt is best read against the cash flow the business throws off each year.